David Kirn, CEO: 4D Molecular Therapeutics FDMT Sell · Filed 23/01/23

Trade details

Type: Insider sale
Amount: $218,306.97
Shares · price: 10,899 sh · $20.03 a share
Held after: 1,902,224 sh
Stock: 4D Molecular Therapeutics FDMT
Person: David KirnCEO
Trade date: 23/01/19
Filed: 23/01/23
Days to filing: 4 days

Sold 0.6% of holdings

Share of holding sold: 0.6%

4D Molecular Therapeutics trades, last 26 weeks

What else happened in 4D Molecular Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/20~23/02/18

David Kirn's recent trades

David KirnSEE REMARKS
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$802.7K
58,333 sh
$802.7K
Filed 09/14
Traded 09/14
David KirnSEE REMARKS
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$1.2M
69,076 sh
$1.2M
Filed 08/19
Traded 08/19
David KirnSEE REMARKS
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$275.4K
26,842 sh
$275.4K
Filed 08/04
Traded 08/04
David KirnSEE REMARKS
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$125.3K
12,415 sh
$125.3K
Filed 08/03
Traded 08/03
David KirnSEE REMARKS
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$193.6K
15,725 sh
$193.6K
Filed 07/10
Traded 07/10

David Kirn, CEO — sold $218.3K of 4D Molecular Therapeutics FDMT · 0.6% of holdings | Whalegun